A major defining genetic event in human MPN is a gain-of-function mutation (V617F) in the JAK2 gene (Baxter et al., 2005; James et al., 2005; Kralovics et al., 2005; Vainchenker and Kralovics, 2017). Here, JAK2 is linked to myeloproliferative neoplasm.